Orally administered nanoparticles treat
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Twitter ~ Facebook
Home / Technology News / 2010 / October 2010 / October 11, 2010
Orally administered nanoparticles to treat inflammatory bowel diseases
RSS / Print / Comments

Technology News

Study to find whether leptin helps type 1 diabetic patients
To determine whether adding the hormone leptin to standard insulin therapy might help rein in the tumultuous blood-sugar levels of people with type 1 (insulin-dependent) diabetes, a clinical trial at UT Southwestern Medical Center is being carried out. ANI

Why deaf have 'super vision'
Researchers have found reasons for the enhanced abilities in the remaining senses of deaf people. ANI

Tsunami risk higher than expected in LA, other major cities
A new study has revealed that the risk of destructive tsunamis is in places such as Kingston, Istanbul, and Los Angeles. ANI

Orally administered nanoparticles to treat inflammatory bowel diseases

Researchers at the Georgia Institute of Technology and Emory University have developed a system for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases.


London, Oct 11 : Researchers at the Georgia Institute of Technology and Emory University have developed a system for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases.

These particles of RNA are encapsulated in particles called thioketal nanoparticles and orally delivered the genetic material directly to the inflamed intestines of animals.

"The thioketal nanoparticles we designed are stable in both acids and bases and only break open to release the pieces of RNA in the presence of reactive oxygen species, which are found in and around inflamed tissue in the gastrointestinal tract of individuals with inflammatory bowel diseases," Nature quoted Niren Murthy at Georgia Tech and Emory University as saying.

These particles protect the RNA from the harsh environment of the gastrointestinal tract and target them directly to the inflamed intestinal tissues.

The researchers used a mouse model of ulcerative colitis -- a debilitating inflammatory bowel disease in which the digestive tract becomes inflamed, causing severe diarrhoea and abdominal pain that can lead to life-threatening complications.

The nanoparticles travelled directly to the mouse colons where reactive oxygen species were being produced in excess and decreased the cytokine production levels there.

Tissue samples from the colons treated with the nanoparticles exhibited intact epitheliums, well-defined fingerlike "crypt" structures and lower levels of inflammation-signs that the colon was protected against ulcerative colitis.

The researchers are currently working on increasing the degradation rate of the nanoparticles and enhancing their reactivity with reactive oxygen species. The team also plans to conduct a biodistribution study to detail how the nanoparticles travel through the body.

In the future, thioketal nanoparticles may become a significant player in the treatment of numerous gastrointestinal diseases linked to intestinal inflammation, including gastrointestinal cancers, inflammatory bowel diseases and viral infections, according to Murthy.

The study is published in the Oct. 10 advance online edition of the journal Nature Materials.

ANI

Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us